1-207761243-TT-G
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 2P and 0B. PM2
The NM_172351.3(CD46):c.476-6_476-5delTTinsG variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_172351.3 splice_region, intron
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Atypical hemolytic-uremic syndrome with MCP/CD46 anomaly Uncertain:1
- -
Atypical hemolytic-uremic syndrome Uncertain:1
This patient is heterozygous for the c.476-6_476-5delinsG variant in the CD46 gene. To our knowledge, this variant has not been previously reported in the literature or any disease specific databases. In silico analysis of pathogenicity (through Alamut Visual v.2.8.1) predicts that this variant may affect splicing. This variant is considered to be a variant of uncertain clinical significance (VOUS) according to the ACMG guidelines. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at